Biogen MA Inc. FDA Inspection Record

FEI 3000719749 · Inspections, Form 483s, warning letters and import refusals

Biogen MA Inc. is an FDA-registered facility (FEI 3000719749) located in Morrisville, NC, US. Registered operations: ANALYSIS; API MANUFACTURE. RegDataLab tracks 12 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jul 12, 2024: No Action Indicated (NAI)
Inspections on record
12 (5 VAI, 7 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
2, latest Dec 9, 2020
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jul 12, 2024No Action Indicated (NAI)No citations listed
Feb 15, 2019Voluntary Action Indicated (VAI)No citations listed
Jun 13, 2018No Action Indicated (NAI)No citations listed
Mar 23, 2017Voluntary Action Indicated (VAI)No citations listed
Jan 15, 2016No Action Indicated (NAI)No citations listed
Jun 19, 2015No Action Indicated (NAI)No citations listed
Nov 14, 2014Voluntary Action Indicated (VAI)No citations listed
Aug 2, 2013Voluntary Action Indicated (VAI)No citations listed
Aug 2, 2013No Action Indicated (NAI)No citations listed
Sep 30, 2011Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 9, 2020Class IID-0148-2021Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count…
Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.
Jun 23, 2020Class IIID-1381-2020Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only…
cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Form 483s and inspection documents

  • 483 on FDA.gov
    Issued Aug 2, 2013 (dates printed on the document). FDA listing date Jul 23, 2015. Published by FDA Jan 18, 2024.

FDA record score

4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIFeb 15, 20196 x 0.251.5
Inspection classified VAIMar 23, 20176 x 0.251.5
Class II recall D-0148-2021, this FEI as the recalling firmDec 9, 20204 x 0.251
Inspection classified VAINov 14, 201410 years or older, so it adds no points0
Inspection classified VAIAug 2, 201310 years or older, so it adds no points0
Inspection classified VAISep 30, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Biogen MA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Biogen MA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Biogen MA Inc.
Location
Morrisville, NC (US)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; API MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.